Cargando…

Androgen receptor in bladder cancer: A promising therapeutic target

There has been a significant progress in the treatment of metastatic urothelial carcinoma in the last few years with the advent of immunotherapy after a long gap of no drug approvals for over 4 decades. While immunotherapy with checkpoint inhibitors has revolutionized the treatment of urothelial car...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Abhishek, Gupta, Shilpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385521/
https://www.ncbi.nlm.nih.gov/pubmed/32742928
http://dx.doi.org/10.1016/j.ajur.2020.05.011